GCC Nurse Guide: Haematology & Blood Transfusion

Packed Red Blood Cells (PRBC)

Attribute	Detail
Volume	~250–350 mL per unit
Storage	2–6°C, up to 35 days
Expected rise	~10 g/L Hb per unit (adult)
General threshold	Hb <70 g/L
Cardiac/elderly	Hb <80 g/L
ACS/symptomatic	Hb <80–100 g/L (clinical judgment)

Leucodepleted standard in GCC Irradiated if immunocompromised CMV-negative if CMV-naive recipient

Fresh Frozen Plasma (FFP)

Attribute	Detail
Volume	~200–300 mL per unit
Storage	−25°C, up to 2 years
Once thawed	Use within 4 hrs (24 hrs if 1–6°C)
Indication	INR >1.5 with active bleeding or procedure
Dose	10–15 mL/kg
Reversal	Warfarin — consider 4-factor PCC first

Not for volume replacement alone ABO compatible required

Platelets

<10K

Prophylactic transfusion

Stable haematology patients

<50K

Procedure/surgery

Most invasive procedures

<100K

Neurosurgery/Obstetric

High-risk sites

Type	Details
Pooled (4–6 donors)	~250–300 mL; more common, less expensive
Apheresis (1 donor)	~200 mL; preferred for HLA-matched, alloimmunised patients
Storage	20–24°C with continuous agitation, 5 days max
Expected rise	30–50 × 10⁹/L per adult dose

Cryoprecipitate & Granulocytes

        Cryoprecipitate
        Contains: Fibrinogen, Factor VIII, vWF, Factor XIII, Fibronectin
Volume: ~10–20 mL per unit; given as pool of 5–10 units
Indication: Fibrinogen <1.5 g/L with bleeding
Massive haemorrhage: target fibrinogen >2 g/L
Storage: −25°C up to 1 year; use within 4 hrs once thawed
Key use: DIC, massive transfusion, haemophilia A (where factor concentrate unavailable)

      

        Granulocytes RARE
        Indication: Prolonged severe neutropenia (<0.5 ×109/L) with life-threatening infection not responding to antibiotics
Fresh product — must be used within 24 hours
Irradiated mandatory to prevent transfusion-associated GvHD
Requires specialist haematologist order

      

Alternatives to Transfusion

          Cell Salvage (Intraoperative Autotransfusion)
          Blood lost during surgery is collected, washed, and re-infused. Common in cardiac, orthopaedic, major vascular surgery. Acceptable to most Jehovah’s Witnesses if circuit remains continuous.
        

          IV Iron (Iron Sucrose / Ferric Carboxymaltose)
          Pre-operative anaemia correction — start 4–8 weeks pre-surgery where possible. Also for chronic iron deficiency where oral iron is not tolerated. Ferric carboxymaltose (Ferinject) widely used in GCC.
        

          Erythropoiesis Stimulating Agents (ESA / EPO)
          Darbepoetin alfa or Epoetin: used in CKD anaemia, chemotherapy-induced anaemia. Pre-operative use with IV iron in Jehovah’s Witnesses. Requires haematologist prescription.
        

          Antifibrinolytics — Tranexamic Acid (TXA)
          Reduces bleeding in trauma, surgery, obstetric haemorrhage. CRASH-2 trial: 1g IV within 3 hrs of injury, repeat at 8 hrs. Dose: 15 mg/kg IV or 1g bolus. Also topical use in ENT and dental.
        

Blood Component Storage Summary

Component	Temperature	Duration	Special Conditions
PRBC	2–6°C	35 days	Must return to blood bank if >30 min out
Platelets	20–24°C	5 days	Continuous agitation required
FFP	−25°C (frozen)	Up to 2 years	Once thawed: 4 hrs (24 hrs at 1–6°C)
Cryoprecipitate	−25°C (frozen)	Up to 1 year	Once thawed: 4 hrs
Granulocytes	20–24°C	24 hours	No agitation; irradiated mandatory
Whole Blood	2–6°C	21–35 days	Rarely used; military trauma contexts

Patient Identification Technique

        ASK, do not TELL
        Say: “Can you please tell me your full name and date of birth?”

        Do NOT say: “Are you Mr Ahmed, born 14th March 1982?” — patients may agree even when confused.
      

Unconscious/confused patients: use wristband only — two nurses verify
Neonates: use mother’s details + cot label
Paediatrics: parent/guardian confirms details
Electronic barcode scanning (EIBBS) now mandated in several GCC hospitals — scan patient wristband + blood unit bag — system alerts if mismatch

Group & Screen vs Group & Crossmatch

Test	When Required
Group & Screen (G&S)	Elective procedures where transfusion possible but unlikely; admission to haematology ward; pre-admission screening
Group & Crossmatch (G&X)	Active bleeding; elective surgery with high probability of transfusion; major procedures; MSBOS requirement
Emergency X-match	Available in 30–45 min (ABO/Rh compatible)
Full crossmatch	60–90 min (full serological)

        Sample Labelling Requirements (Zero-error policy)
        Full name, DOB, MRN, date/time collected, collector’s signature. Samples must be hand-labelled at the bedside — never pre-labelled or labelled away from patient.
      

Emergency O-Negative Blood

Use when: life-threatening haemorrhage with no time for crossmatch
O-negative: universal donor for red cells (no ABO antigens, Rh-negative)
Switch to crossmatched blood as soon as available
O-negative stock is limited — reserve for women of childbearing age and children where possible
O-positive acceptable for males and post-menopausal females in extreme emergency
Document emergency issue; notify blood bank immediately

Maximum Surgical Blood Order Schedule (MSBOS)

MSBOS guides pre-operative crossmatch requests to avoid unnecessary blood reservation.

Procedure	Recommendation
Cholecystectomy (laparoscopic)	G&S only
Appendicectomy	G&S only
Hip replacement (elective)	2 units crossmatched
CABG/Open heart	4–6 units crossmatched
Liver resection	4 units + FFP
Caesarean section (elective)	G&S only
Caesarean section (high risk)	2–4 units crossmatched

Rate of Administration

Component	Standard Rate	Key Rule
PRBC	2–4 hrs per unit	MUST complete within 4 hrs of leaving blood bank
Platelets	30–60 min per dose	Infuse promptly; do not store at bedside
FFP	30 min per unit	Rapid infusion acceptable if bleeding
Cryoprecipitate	30 min per pool	Use within 4 hrs once thawed
Granulocytes	2–4 hrs	Irradiated; use within 24 hrs

        4-Hour Rule for PRBC
        If a unit cannot be completed within 4 hours of leaving the blood bank at 2–6°C, it must be discarded. Document start time on the bag label and nursing notes.
      

IV Access & Equipment

        Cannula Size
        18G minimum recommended for standard transfusion. 14–16G for rapid transfusion / massive haemorrhage. Smaller gauges (>20G) increase haemolysis risk and slow flow rate.
      

Blood giving set: Use dedicated blood administration set with integral 170–200 micron filter
Change giving set: After every 2 units PRBC, or every 4 hours, or per local policy
No medications to be added to blood component or given through same line without flushing
Normal saline (0.9% NaCl) only for flushing — NOT Hartmann’s (calcium causes clotting) — NOT dextrose (haemolysis)
Blood warmer indications: Massive transfusion (>50 mL/kg/hr), neonatal transfusion, cold agglutinin disease, patients at risk of hypothermia, rapid infusion >100 mL/min

Observations Schedule

Baseline (Pre-Transfusion)

Temperature, Pulse, BP, RR, SpO2 — record within 30 min before starting. Assess for symptoms. Confirm IV access patent.

15 Minutes Into EACH Unit CRITICAL WINDOW

Temp, Pulse, BP, RR, SpO2. Assess patient symptoms actively — ask about back pain, rigors, urticaria, dyspnoea. Most severe reactions occur early. If any change: STOP and assess.

1 Hour Into Each Unit

Temp, Pulse, BP, RR, SpO2. Continue symptom assessment. Verify rate of infusion.

End of Each Unit

Temp, Pulse, BP, RR, SpO2. Document completion time. Flush line. Discard giving set as per policy.

Post-Transfusion (1 hr after last unit)

Full set of observations. Document in transfusion record. Note any delayed symptoms. Post-transfusion Hb (FBC) typically checked 1–6 hrs after completion.

      What to observe & ask at each check
      Temperature rise ≥1°C from baseline; Pulse change >20 bpm; BP drop >20 mmHg systolic; New dyspnoea or SpO2 drop; Patient reports: rigors, back/loin pain, chest pain, headache, urticaria, metallic taste, feeling of ‘impending doom’
    

Special Transfusion Requirements

Requirement	Indication	Product Label
Irradiated	Haematopoietic stem cell transplant, congenital immunodeficiency, neonates, directed donations (relative), Hodgkin lymphoma, purine analogue therapy (Fludarabine)	Gamma-irradiated / X-ray irradiated
CMV-negative	CMV-seronegative pregnant women, CMV-seronegative SCT recipients (if donor also seronegative)	CMV antibody negative
Phenotypically matched	Sickle cell disease (extended crossmatch: C, c, E, e, K, Fy^a, Jk^a), multiply alloimmunised patients, Thalassaemia major	Antigen-negative units
Washed	Severe IgA deficiency (anaphylaxis risk), recurrent severe allergic reactions	Washed red cells
HLA-matched platelets	Platelet refractoriness due to HLA alloimmunisation	HLA-matched / crossmatch-compatible

Acute Haemolytic Transfusion Reaction (AHTR)

      MOST DANGEROUS — Usually due to ABO incompatibility (wrong blood to wrong patient)
    

Signs & Symptoms

Fever, rigors, chills
Severe back/loin pain, flank pain
Haematuria (red/dark urine)
Haemodynamic collapse (hypotension, tachycardia)
DIC (bleeding from multiple sites)
Feeling of ‘impending doom’ (patient may say “something is very wrong”)
Renal failure (oliguria/anuria)

Immediate Nursing Management

STOP transfusion immediately
Keep IV line open with 0.9% NaCl — do NOT remove cannula
Call doctor urgently — activate emergency response if collapse
Send blood component and giving set back to blood bank intact
Collect urine sample — check for haemoglobinuria
Urgent bloods: FBC, U&E, LFTs, coagulation, Group & Crossmatch, DCT (Direct Coombs Test), LDH, bilirubin
Document exact volume transfused, time started, observations
Complete haemovigilance incident report (SHOT / local system)

Febrile Non-Haemolytic Reaction (FNHTR)

        Most common transfusion reaction (1–2% of transfusions)
        Cause: Cytokines in stored blood or recipient antibodies to donor leucocytes
      

Signs:

Temperature rise ≥1°C, fever, chills, rigors
NO haemolysis, NO haemodynamic instability

Management:

SLOW transfusion rate or temporarily pause
Administer paracetamol (antipyretic) as prescribed
Monitor observations every 15 min
If improving — may cautiously continue
If fever >39°C or other symptoms develop — STOP, treat as possible AHTR
Document and report; consider pre-medication for future units

Allergic Reaction / Anaphylaxis

Spectrum from mild urticaria to life-threatening anaphylaxis

Signs (mild to severe):

Urticaria, pruritus, rash (mild)
Angioedema, bronchospasm, stridor
Anaphylaxis: hypotension, bronchospasm, collapse

Management:

Mild urticaria only: slow rate, give chlorphenamine IV, observe
Angioedema/bronchospasm: STOP transfusion, chlorphenamine + hydrocortisone
Anaphylaxis: STOP, adrenaline 0.5 mg IM (1:1000), call emergency team, airway support
IgA-deficient patients: use washed cells / IgA-deficient donor products for future

TACO — Transfusion-Associated Circulatory Overload

        Most common cause of transfusion-related mortality in developed countries
        Risk: elderly, cardiac failure, CKD, low body weight, rapid transfusion
      

Signs (within 6 hrs):

Acute dyspnoea, orthopnoea
Hypertension (new or worsening)
Bilateral basal crackles on auscultation
SpO2 drop, peripheral oedema
CXR: bilateral infiltrates, cardiomegaly
BNP/NT-proBNP elevated

Management:

Slow or STOP transfusion
Sit patient upright
Oxygen therapy
Furosemide IV (diuretic) as prescribed
Monitor fluid balance closely
Prevention: single unit at a time, furosemide between units for at-risk patients

TRALI — Transfusion-Related Acute Lung Injury

        Leading cause of transfusion fatality — non-cardiogenic pulmonary oedema
        Mechanism: donor anti-HLA/HNA antibodies activate recipient neutrophils in lung capillaries
      

Signs (within 6 hrs, usually 1–2 hrs):

Acute severe dyspnoea, hypoxia
Bilateral pulmonary infiltrates on CXR
NO hypertension (differentiates from TACO)
Fever, hypotension possible
No evidence of circulatory overload

Management:

STOP transfusion immediately
High-flow oxygen; escalate to ICU if severe
Supportive care — may need mechanical ventilation
Do NOT give diuretics (distinguishing from TACO)
Report to blood bank; investigate donor
Most patients recover within 96 hrs with support

Interactive Transfusion Reaction Identifier

Select the symptoms and timing to identify the most likely reaction and immediate nursing action.

SYMPTOMS (select all that apply):

TIMING:

Massive Transfusion Protocol (MTP)

      Definition: >10 units PRBC within 24 hours OR >4 units in 1 hour OR anticipated requirement. Activating MTP triggers coordinated multidisciplinary response.
    

Pack Ratio — Damage Control Resuscitation

PRBC

FFP

Platelets

1:1:1 ratio (PRBC:FFP:Platelets) in trauma/haemorrhage — replaces coagulation factors lost with blood. Goal: prevent ‘lethal triad’ of hypothermia, acidosis, coagulopathy.

MTP Bundle — Nursing Actions

Tranexamic acid 1g IV within 3 hrs of haemorrhage (CRASH-2 trial evidence); repeat 1g at 8 hrs
Calcium replacement: Citrate in blood binds ionised calcium — give 10 mL calcium gluconate 10% every 4 units
Hypothermia prevention: Warm all blood products via blood warmer, warm IV fluids, warming blankets, raise room temperature
Acidosis monitoring: Serial ABGs, lactate
Point-of-care coagulation: TEG (Thromboelastography) or ROTEM (Rotational Thromboelastometry) guides targeted factor replacement
Cryoprecipitate if fibrinogen <2 g/L (target >2 g/L in haemorrhage)

Sickle Cell Disease (SCD) Transfusion

        Indications for transfusion in SCD
        Acute chest syndrome, stroke (primary/secondary prevention), splenic/hepatic sequestration, multi-organ failure, pre-operative (Hb <90 g/L), severe aplastic crisis
      

Simple vs Exchange Transfusion:

Type	Use	Target
Simple top-up	Anaemia, aplastic crisis, splenic sequestration	Hb 90–100 g/L; do NOT exceed 110 g/L (hyperviscosity)
Exchange transfusion	Acute stroke, severe acute chest, multi-organ failure	HbS% <30%; Hb 90–100 g/L

        Extended Crossmatch (Phenotypically Matched Blood)
        SCD patients must receive blood matched for: C, c, E, e, K, Fya, Fyb, Jka, Jkb antigens to reduce alloimmunisation risk. Document all patient alloantibodies.
      

Haemophilia Nursing

        Haemophilia A: Factor VIII deficiency — X-linked recessive

        Haemophilia B: Factor IX deficiency (Christmas disease)

Factor Concentrate Administration:

Reconstitute with provided diluent — gently rotate (do NOT shake)
Administer IV slowly (3–5 mL/min) via butterfly or peripheral cannula
Recombinant factors preferred; plasma-derived if unavailable
Document: factor name, batch number, expiry, dose, time — traceability mandatory
Home therapy — teach patient/family self-infusion technique

Joint Bleed (Haemarthrosis) First Aid — RICE:

R — Rest I — Ice (wrapped) C — Compression E — Elevation

Administer factor concentrate FIRST, then RICE. Target joints (recurrent bleeds): physiotherapy + prophylactic factor essential.

Immune Thrombocytopaenia (ITP) Nursing

Platelet transfusion generally NOT indicated in ITP (antibodies destroy donor platelets rapidly)
Platelet transfusion ONLY for life-threatening bleeding (intracranial, massive GI)
First-line: Prednisolone (corticosteroids), IVIG (IV Immunoglobulin)
Second-line: Rituximab, Thrombopoietin receptor agonists (Eltrombopag, Romiplostim)
Splenectomy: ensure vaccinated (pneumococcal, meningococcal, Hib) 2 weeks before
Nursing: bleeding precautions, soft toothbrush, avoid IM injections, fall prevention, no NSAIDs/aspirin
Monitor for signs of intracranial bleed: headache, confusion, GCS drop

Coagulation Factor Disorders — Nursing Overview

Condition	Missing Factor	Key Treatment
vWD (Von Willebrand Disease)	vWF (± Factor VIII)	DDAVP (desmopressin), Factor VIII/vWF concentrate, TXA
DIC	Multiple (consumed)	Treat cause; FFP, cryo, platelets; heparin in chronic DIC
Liver disease coagulopathy	All liver-made factors (except vWF)	Vitamin K IV, FFP; avoid over-correction (PT/INR unreliable guide)
Warfarin toxicity	Vitamin K-dependent (II, VII, IX, X)	Vitamin K PO/IV; 4-factor PCC (Beriplex); FFP if PCC unavailable
Direct oral anticoagulant (DOAC) reversal	Xa or IIa inhibitors	Andexanet alfa (Xa); Idarucizumab (dabigatran)

Sickle Cell Disease in the GCC

          Saudi Arabia
          Among the highest SCD rates globally — concentrated in the Eastern Province (Al-Ahsa, Qatif) and Jizan region. Dedicated Sickle Cell Centers (e.g., Qatif Central Hospital Sickle Cell Program). National neonatal screening programme. SCD prevalence ~8–10% carrier rate in endemic areas.
        

          Bahrain & Kuwait
          Significant SCD prevalence in Bahraini and Kuwaiti nationals. National screening and patient registries established. Bahrain introduced mandatory premarital testing.
        

          Oman
          High SCD prevalence particularly in Al-Batinah and Dhofar regions. Oman National Genetic Centre provides counselling and screening. Organised chronic transfusion programmes for stroke prevention.
        

          UAE & Qatar
          Emirati population has significant SCD prevalence. Large African expatriate community adds to case burden in UAE. Qatar has national screening programme. Pain management protocols in SCD centres follow international guidelines with local adaptations.
        

G6PD Deficiency in the GCC

        Very common in GCC Arab populations and South Asian expat communities
        Carrier rates: 5–20% in parts of Saudi Arabia, Oman, Kuwait, Bahrain. X-linked recessive — males predominantly affected; females can be symptomatic if homozygous.
      

Triggers to Avoid (Nurse Education):

Foods:

Fava beans (ful medames — very common in GCC diet)
Red wine (less relevant in GCC but educate)

Medications to Avoid:

Primaquine (antimalarial)
Nitrofurantoin (UTI treatment)
Dapsone
High-dose aspirin
Rasburicase (caution in haematology)
Some sulfonamides

Haemolytic Crisis Signs:

Sudden pallor, jaundice
Dark urine (haemoglobinuria)
Back/abdominal pain
Fatigue, dyspnoea

Management:

Remove trigger
Hydration
PRBC transfusion if severe anaemia
Monitor renal function
Folic acid supplementation

Thalassaemia in the GCC

        High carrier rates across the GCC — national screening critical
        Beta-thalassaemia carrier rates: Bahrain ~2%, Oman ~3%, UAE ~2%, Qatar ~2–3%. National premarital screening programmes in all GCC states. Aim: prevent thalassaemia major births.
      

Thalassaemia Major Nursing:

Chronic transfusion programme: PRBC every 2–4 weeks, target pre-transfusion Hb 90–100 g/L
Phenotypically matched blood essential (extended crossmatch)
Iron overload monitoring: Annual serum ferritin, liver MRI (T2*), cardiac MRI
Chelation therapy:
- Desferrioxamine (Desferal): SC infusion over 8–12 hrs, 5–7 nights/week; injection site rotation
- Deferasirox (Exjade): oral once daily; monitor renal function & LFTs monthly
- Deferiprone (Ferriprox): oral TID; weekly FBC for agranulocytosis
Splenectomy in hypersplenism — post-splenectomy vaccinations and lifelong penicillin prophylaxis
Bone marrow/stem cell transplant: curative option; nursing care per SCT protocols

Blood Donation in the GCC

        Key Challenge: Low voluntary non-remunerated donation rates
        GCC countries rely heavily on replacement (family) donation. National blood banks actively running awareness campaigns to shift to voluntary donation model (WHO target: 100% voluntary).
      

Country	Notes
Saudi Arabia	NBAD (National Blood & Cancer Center); campaigns during Ramadan and National Day drive donations
UAE	Dubai Blood Donation Centre & Abu Dhabi Blood Bank; Indian community historically strong voluntary donors
Kuwait	Kuwait Central Blood Bank; growing voluntary donation culture
Qatar	Hamad Blood Bank; mandatory testing pre-donation including TTIs
Bahrain	National Blood Bank; community drives in mosques and workplaces

All GCC countries test donated blood for: HIV, Hepatitis B & C, Syphilis, HTLV; and some also test for Malaria and Brucella.

Religious & Cultural Considerations

        Islam and Blood Transfusion
        Blood transfusion is generally permissible in Islam under the principle of darurah (necessity) and ijtirar (dire need/compulsion). The Quran states: “Whoever saves a life, it is as if he has saved all mankind” (5:32). Major Islamic scholarly bodies (including Saudi Arabia’s Council of Senior Scholars) have issued rulings permitting transfusion when medically necessary. Family donors are often preferred culturally. Nurses should facilitate informed consent discussions sensitively.
      

Jehovah’s Witnesses
        Rare in the GCC but present (primarily expatriate community). Refuse whole blood, PRBC, FFP, and platelets. May accept minor blood fractions (albumin, clotting factors) — varies by individual conscience. Nurses must:
        Ensure informed refusal is documented (advance directive)
Involve haematology and hospital ethics committee early
Offer maximum bloodless surgery alternatives:

          Cell salvage
          IV iron
          Erythropoietin
          Tranexamic acid
          Normovolaemic haemodilution
          Hypotensive anaesthesia
        

Haemovigilance & Incident Reporting in GCC

All transfusion reactions must be documented in the patient’s notes, transfusion record, and reported to the blood bank immediately
Serious reactions reported to national haemovigilance systems (Saudi Arabia: SFDA Blood & Biological Products; UAE: DOH/MOH haemovigilance)
SHOT (Serious Hazards of Transfusion) framework adopted by many GCC hospitals with international affiliations (Joint Commission International — JCI accredited)
Never discard a blood unit involved in a reaction — return intact with giving set to blood bank
Near-miss errors (wrong blood to wrong patient avoided) must also be reported — critical for system improvement

Haematology & Blood Transfusion Nursing

Interactive Transfusion Reaction Identifier